Skip to main content
. 2018 Mar 21;12:183. doi: 10.3389/fnins.2018.00183

Figure 4.

Figure 4

The effect of CRFR2 antagonist (As2B) on OT content in BNSTdl microdialysates is modulated by CRFR1 manipulation. The effect of As2B on OT release at 30 min was occluded by intra-BNSTdl application of CRFR1 antagonist NBI 35965 (n = 6, teal, open circle, P < 0.05) as well as application of CRF (n = 7, blue diamond, P < 0.01). The delayed stimulatory effect of As2B at 90 min was not affected by CRF or NBI 35965 application (P > 0.05). **P < 0.01, *P < 0.05, two-way ANOVA with repeated measures.